KALV
KalVista Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.00
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+59.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 29, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | Sale | 33,800 | $27 |
| May 29, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | M-Exempt | 33,800 | $7.07 |
| May 27, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | M-Exempt | 3,125 | $0.00 |
| May 27, 2026 | Sweeny Nicole · officer: Chief Commercial Officer | M-Exempt | 5,000 | $0.00 |
| May 27, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | Sale | 1,966 | $27 |
| May 27, 2026 | Sweeny Nicole · officer: Chief Commercial Officer | Sale | 1,489 | $27 |
| May 27, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | M-Exempt | 5,000 | $0.00 |
| May 27, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | Sale | 2,239 | $27 |
| May 26, 2026 | Piekos Brian · officer: Chief Financial Officer | Sale | 1,489 | $27 |
| May 26, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | Sale | 2,685 | $27 |
| May 26, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | M-Exempt | 6,250 | $0.00 |
| May 26, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | Sale | 2,358 | $27 |
| May 26, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 23,250 | $0.00 |
| May 26, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 10,926 | $27 |
| May 26, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | M-Exempt | 3,750 | $0.00 |
| May 26, 2026 | Sweeny Nicole · officer: Chief Commercial Officer | Sale | 1,861 | $27 |
| May 26, 2026 | Piekos Brian · officer: Chief Financial Officer | M-Exempt | 5,000 | $0.00 |
| May 26, 2026 | Sweeny Nicole · officer: Chief Commercial Officer | M-Exempt | 6,250 | $0.00 |
| May 19, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | M-Exempt | 2,419 | $0.00 |
| May 19, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | Sale | 1,108 | $27 |
| May 19, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 2,419 | $0.00 |
| May 19, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,129 | $27 |
| May 19, 2026 | Yea Christopher · officer: CHIEF DEVELOPMENT OFFICER | M-Exempt | 1,774 | $0.00 |
| May 19, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | Sale | 1,032 | $27 |
| May 13, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 7,120 | $0.00 |
| May 13, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 3,322 | $27 |
| Apr 20, 2026 | Piekos Brian · officer: Chief Financial Officer | M-Exempt | 6,250 | $0.00 |
| Apr 20, 2026 | Sweeny Nicole · officer: Chief Commercial Officer | Sale | 1,862 | $20 |
| Apr 20, 2026 | Audhya Paul K. · officer: CHIEF MEDICAL OFFICER | Sale | 2,686 | $20 |
| Apr 20, 2026 | Palleiko Benjamin L · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 20,312 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 41Increased 66Reduced 47Sold out 182
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VR ADVISER, LLC | Reduced | 6,474,485 | May 15, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Reduced | 4,961,108 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 4,768,712 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 4,573,530 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 3,795,897 | May 13, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | Increased | 2,876,407 | May 14, 2026 |
| CAPITAL WORLD INVESTORS | Unchanged | 2,808,583 | May 13, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 2,430,000 | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 2,136,940 | May 15, 2026 |
| STATE STREET CORP | Increased | 1,955,844 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 1,912,146 | May 15, 2026 |
| VESTAL POINT CAPITAL, LP | Reduced | 1,850,000 | May 15, 2026 |
| PARKMAN HEALTHCARE PARTNERS LLC | Increased | 1,835,506 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,830,467 | May 15, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Increased | 1,820,954 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 29, 2026